●
Earnings Feed
Filings
Companies
Insiders
Pricing
Blog
⌘
K
Login
Start Free
MED DIVERSIFIED INC
·
8-K/A
May 24, 4:21 PM ET
Share
MED DIVERSIFIED INC 8-K/A
Loading document...
Share
More
Contents
26
a) Motion for an Order Directing Joint Administration of Cases Pursuant to Fed. R. Bankr. P. 1015(b);
b) Emergency Motion for Order Authorizing Debtors to Pay Certain Pre-Petition Wages, Payroll Taxes, Employee Benefits, Reimbursable Expenses and Insurance;
c) Motion for Order Authorizing (1) Maintenance of Pre-Petition Bank Accounts; and (2) Continued Use of Business Forms; and
d) Debtors’ Emergency Motion for Interim and Final Orders Authorizing Use of Cash Collateral.
a) Network Pharmaceuticals;
b) Dr. Murray Firestone;(4)
c) Mr. George Kuselias(5)
d) The Moncrief Settlement & Trust; and
e) Mr. Thomas Campbell
a) Authorized the Debtors to enter into a Master Purchase and Sale Agreement with Sun Capital, pursuant to which the Debtors were authorized to sell to Sun Capital to obtain necessary financing certain of their accounts receivable not previously factored to NCFE.
b) As security for the Debtors’ obligations thereunder, granted Sun Capital first priority liens on all of the Debtors’ postpetition
receivables and all of their “post-cutoff date” prepetition receivables and a super-priority administrative expense claim, other than with respect to certain “Carve-Out Expenses”; and
c) Granted junior liens and superpriority expense claims to NCFE and the Bank as adequate protection for any further use of their cash collateral or diminution in its value, subject to the liens and superpriority administrative expense claims granted to Sun Capital.
(i) The Objection to Bank’s Claim
(ii) The Motion to Substantively Consolidate
(iii) The Settlement
(iv) Analysis of the Settlement
a) Due diligence by parties interested in submitting an offer to purchase any or all of the TLC Debtors’ or Med Debtors’ assets or businesses and/or fund a plan or plans of reorganization for any of the Debtors and wishing to be considered as a so-called “Stalking Horse Bid” was to be completed by 5:00 p.m. on November 21, 2003.
b) Written offers were to be submitted by 5:00 p.m. on November 25, 2003, which offers were to be shared with the legal and financial advisors of the Bank, NCFE, the CCG Committee, the Med Committee and the TLC Committee (collectively, the “Oversight Committee”).
c) Two in-person meetings and weekly conference calls were to take place among the Facilitator, the Med and TLC Debtors and the Oversight Committee to discuss the sale process and to discuss any and all bids and the selection of one or more Stalking Horse Bids.
d) Subject to the input and agreement of the Oversight Committee, the Debtors, on or before December 10, 2003 could select one or more parties submitting an offer to finalize one or more Staking Horse Bids. In the event the Debtors and the Oversight Committee could not reach agreement, the Facilitator could make the selection. However the Procedures Order also provided that the Debtors, the Oversight Committee and the
Facilitator also could agree not to select a Stalking Horse Bid from the offers submitted.
a) Ordered the Debtors or the Med Committee to submit the agreement for the sale of the NCOE’s to US Health and notice it for hearing at 10:00 a.m. on March 12, 2004;
b) Ordered the Debtors to file this Disclosure Statement and Plan by 4:00 p.m. on March 5, 2004;
c) Scheduled the initial hearing on the adequacy of such Disclosure Statement for April 2, 2004 at 10:00 a.m.
(i) Generally
Contents
Share
More
Download PDF